Frontiers in Cardiovascular Medicine

JANUARY 31, 2025

IntroductionVentricular assist devices (VADs) are lifesavers for people with advanced heart failure. These data are crucial for driving innovation in this field and for improving the lives of patients who depend on VADs.

Document 80

Document Innovation Heart Failure Technology 80

DAIC

FEBRUARY 10, 2025

Additionally, the algorithm demonstrated its ability to pinpoint specific, clinically relevant segments of heart sound recordings, offering a transparent and explainable AI approach that aligns with physicians diagnostic workflows. The companys goal is to develop pioneering AI solutions that address significant gaps in healthcare delivery.

Research 64

Research Innovation Pulmonary Hypertension 64

HCPLive

AUGUST 27, 2024

Allegheny Health Network (AHN) implants innovative device to manage central sleep apnea in heart failure patients, reducing mortality rise and improving quality of life.

Innovation 40

Innovation Heart Failure Quality of Life 40

DAIC

FEBRUARY 14, 2025

The retrospective analysis of data from the MODERATO II study demonstrated that AVIM therapy significantly improved echocardiographic (Echo) markers of diastolic dysfunction, an important component in the development of heart failure, in hypertensive patients. Advanced Heart Failure Cardiologist, Duke Health on Feb.

Blood Pressure 52

Blood Pressure Heart Failure Hypertension Technology 52

Becker's Hospital Review - Cardiology

AUGUST 19, 2024

"Discover the latest innovation in heart failure screening with an at-home testing device created by Colorado State University. Learn more at the American Chemi

Heart Failure 52

Heart Failure Research Innovation 52

DAIC

MARCH 5, 2024

Early Feasibility Study (FUTURE-HF2) of its FIRE1 System for remote heart failure monitoring. The FIRE1 System is the first device designed to directly measure a patient’s volume status by measuring the largest vein in the body where most fluid is stored – the inferior vena cava (IVC) – to better manage heart failure.

Heart Failure 52

Heart Failure Innovation Hospital Technology 52

American College of Cardiology

NOVEMBER 5, 2024

The idea that obesity increases the risk of heart failure seems like an obvious conclusion. After all, as the Framingham Heart Study clearly showed, obesity and overweight are significantly associated with a higher risk of hypertension, angina and coronary heart disease.

Heart Failure 43

Heart Failure Innovation Angina Obesity 43

HCPLive

MARCH 14, 2024

The AccuCinch® System, utilized by Allegheny General Hospital, offers a breakthrough approach to treating heart failure by targeting the left ventricle.

Quality of Life 52

Quality of Life Heart Failure Cardiac Function Innovation 52

DAIC

MAY 17, 2024

Based on the Health Data Hub complete medico-administrative database and comprehensive datasets from Implicity's AI -based remote monitoring platform, the Implicity team trained and validated a machine learning algorithm that assesses the risk of future heart failure events, enabling physicians to intervene before a patient requires hospitalization.

Heart Failure 52

Heart Failure Pacemaker Hospital Defibrillator 52

DAIC

JUNE 5, 2024

The sale enhances Edwards’ balance sheet flexibility for disciplined investments in technologies for aortic, mitral, tricuspid and pulmonic patients, as well as new therapeutic areas for interventional heart failure. Critical Care has made significant contributions to our company and has a long history of pioneering innovation.

Critical Care 105

Critical Care Tricuspid Innovation Bicuspid/Mitral 105

DAIC

MAY 30, 2024

milla1cf Thu, 05/30/2024 - 10:31 May 30, 2024 — Stereotaxis , a pioneer in surgical robotics for minimally invasive endovascular intervention, announced the successful treatment of the first heart rhythm patients by Penn Presbyterian Medical Center (PPMC) utilizing the advanced Genesis Robotic Magnetic Navigation System.

Technology 105

Technology Heart Rhythm Hospital Cardiac Arrest 105

DAIC

FEBRUARY 21, 2024

However, there is a notable gap in device options for infants and young children with end stage heart failure. Although tools for the youngest heart patients are limited, the Ochsner Children’s Hospital team provides top-of-the-line care to bridge patients safely to transplant and a hope for a better quality of life.

Pediatrics 105

Pediatrics Hospital Heart Failure Transplant 105

DAIC

DECEMBER 18, 2024

12, 2024 Physicians have a new treatment option for many of the sickest pediatric patients with heart failure andcardiogenic shock. and Impella CP enable heart recovery as part of the world's smallest heart pump platform. with SmartAssist tim.hodson Wed, 12/18/2024 - 14:06 Dec.

Pediatrics 52

Pediatrics Cardiogenic Shock Heart Failure Quality of Life 52

DAIC

JANUARY 15, 2024

Cardiac amyloidosis is a heterogeneous disease that results from the accumulation of abnormal proteins within the heart, impairing its ability to pump blood. Over time, the build-up of these proteins causes the heart muscle to stiffen, eventually leading to heart failure, which can have dire outcomes if not found early.

Ultrasound 119

Ultrasound Coronary Artery Disease Innovation Heart Failure 119

DAIC

FEBRUARY 18, 2025

Catheter-based procedures offer an alternative for patients who are not candidates for open-heart surgery. Studies estimate that severe regurgitation occurs in up to 4% of individuals 75 and older and is often linked with conditions like heart failure, atrial fibrillation or pulmonary hypertension.

Tricuspid 52

Tricuspid Open-Heart Surgery Quality of Life Anatomy 52

Circulation: Genomic and Precision Medicine

MAY 20, 2024

In this review, we present the available literature reporting omics data on heart failure that can inform the development of novel treatments or innovative treatment strategies for this disease. Examples of omics data include genomics, transcriptomics, epigenomics, proteomics, metabolomics, and more.

Heart Failure 40

Heart Failure Innovation Circulation 40

DAIC

JANUARY 5, 2024

Patients Implanted with Innovative FIRE1 Remote Heart Failure Monitoring System in Early Feasibility Study Atrial Fibrillation Market Reaches $20.92B, According to New Report 9. Medtronic Receives FDA Approval for its Next Generation Micra Leadless Pacing Systems 10.

Atrial Fibrillation 105

Atrial Fibrillation Aortic valve Cardiothoracic Interventional Cardiology 105

DAIC

JUNE 11, 2024

Tricuspid and mitral valves are debilitating conditions that can lead to arrhythmias, hypertension, and heart failure. Until recently, therapeutic options for people with tricuspid and mitral valve disorders have been limited to symptom relief or high-risk surgery.

Tricuspid 111

Tricuspid Bicuspid/Mitral Heart Valves Innovation 111

DAIC

FEBRUARY 12, 2024

A team at Allina Health Minneapolis Heart Institute at Abbott Northwestern Hospital has successfully completed the first Barostim Baroreflex Activation Therapy implant in the state of Minnesota, according to an announcement from CVRx, Inc. and Allina Health. and Allina Health. and Allina Health.

Heart Failure 52

Heart Failure Hospital Quality of Life Heart Attack 52

DAIC

JULY 12, 2024

Lead researcher Dr Pankaj Garg , of the University of East Anglia’s Norwich Medical School and a consultant cardiologist at the Norfolk and Norwich University Hospital, heads up a team of researchers who have pioneered innovative and revolutionary 4D MRI imaging technology.

Outcomes 122

Outcomes Hospital Research Innovation 122

DAIC

MAY 21, 2024

milla1cf Tue, 05/21/2024 - 08:00 May 21, 2024 — Stereotaxis , a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it has been invited to present at HRS Africa Summit 2024 , scheduled to take place during Heart Rhythm Society Scientific Sessions in Boston, Massachusetts.

Heart Rhythm 52

Heart Rhythm Innovation Electrophysiology Technology 52

Journal of Cardiovascular Pharmacology

OCTOBER 9, 2023

Sodium-glucose cotransporter 2 (SGLT2) inhibitors represent one of the most important pharmacological innovations in the field of Cardiology of the last decades, having shown significant outcome improvement in all the heart failure (HF) spectrum. However, cost-effectiveness considerations should be made.

Heart Failure 40

Heart Failure Pharmacology Innovation Outcomes 40

DAIC

JUNE 3, 2024

The HighLife technology will be featured at NY Valves annual meeting on Thursday, June 6th at 11am in the session “Innovation at NYV: Transfemoral TMVR - Technology and Clinical Updates” - Room: Innovation & FDA, 504, Level 5, Jacob K. Javits Convention Center, North.

Bicuspid/Mitral 105

Bicuspid/Mitral Technology Open-Heart Surgery Innovation 105

DAIC

JANUARY 8, 2024

David Gibson, 75, of Walbridge, Ohio, traveled 100 miles to undergo care with UH Harrington Heart & Vascular Institute. He was diagnosed with extensive coronary artery disease, resulting in ischemic cardiomyopathy and heart failure. His heart was weak and did not pump well due to blockages in his coronary arteries.

Bicuspid/Mitral 124

Bicuspid/Mitral Atrial Fibrillation Anatomy Coronary Artery Disease 124

Open Heart

NOVEMBER 4, 2022

Introduction The diagnostic and therapeutic arsenal for heart failure with preserved ejection (HFpEF) has expanded. We; therefore, evaluated the efficacy of an existing dedicated HFpEF clinic to find innovative ways to design a more comprehensive model tailored to the modern era of HFpEF.

Preserved Ejection Fraction 52

Preserved Ejection Fraction Heart Failure COVID-19 Outpatient 52

DAIC

JUNE 11, 2024

Tens of millions of individuals worldwide suffer from arrhythmias – abnormal heart rhythms that result when the heart beats too quickly, too slowly, or with an irregular pattern. When left untreated, arrhythmias may significantly increase the risk of stroke , heart failure , and sudden cardiac arrest.

Heart Rhythm 81

Heart Rhythm Technology Electrophysiology Arrhythmia 81

American College of Cardiology

APRIL 4, 2024

Increasing diversity in clinical trial enrollment may impact who receives early application of recently approved innovations, based on findings from a study conducted on behalf of the Heart Failure Collaboratory and being presented at ACC.24 24 in Atlanta, GA.

Innovation 51

Innovation Heart Failure Article 51

DAIC

JANUARY 16, 2024

There, he served as an investigator in many high-profile clinical trials, including several significant structural heart studies. Dr. Shreenivas is a frequent speaker at major scientific meetings and has been widely published in peer-reviewed journals across the structural heart, heart failure, and coronary arenas.

Bicuspid/Mitral 59

Bicuspid/Mitral Heart Failure Catheterization Laboratory Innovation 59

DAIC

JULY 15, 2024

Health systems leveraging Guidehealth can seamlessly integrate Story Health’s program to support at-risk patients with heart conditions like heart failure, hypertension, and arrhythmia, providing better care while also reducing the total cost of care, according to a written statement detailing the deal.

Technology 105

Technology Innovation Nursing Heart Failure 105

CardiacWire

FEBRUARY 21, 2024

Reprieve Cardiovascular emerged this week , announcing a hefty $42M Series A round and an even bigger mission to “transform the standard of care” for patients with acute decompensated heart failure. The post Reprieve Cardiovascular Looks to Transform ADHF Decongestion Management appeared first on Cardiac Wire.

Innovation 59

Innovation Heart Failure Patient Care Hospital 59

DAIC

MAY 21, 2024

ECG-AI LEF , the company’s breakthrough AI algorithm using routine 12-lead ECG data to detect Low Ejection Fraction (LEF), a commonly undiagnosed indicator of heart failure , 1 received U.S. Food and Drug Administration ( FDA ) clearance in September 2023, and is currently under review in Europe.

Certification 97

Certification Technology Innovation Heart Failure 97

DAIC

APRIL 3, 2024

24 is guided by prominent clinicians and leaders, and focuses on important fundamentals in managing and treating heart conditions. This includes a review of updated clinical guidelines and best practices. Each session is interactive and includes knowledge check-ins and dedicated time for discussion. 24 news here.

Education 105

Education Preserved Ejection Fraction Coronary Artery Disease Cardio Oncology 105

Frontiers in Cardiovascular Medicine

JANUARY 18, 2024

Adipose-derived mesenchymal stem cells (ASCs) represent an innovative candidate to treat ischemic heart disease (IHD) due to their abundance, renewable sources, minor invasiveness to obtain, and no ethical limitations.

Heart Disease 64

Heart Disease Myocardial Infarction Transplant Atherosclerosis 64

DAIC

JUNE 27, 2024

“It is exciting to see the convergence of our pioneering work in artificial intelligence and remote patient monitoring through this new partnership between Anumana and InfoBionic.Ai,” said Peter Noseworthy, MD, chair of the Heart Rhythm Services Division of Cardiovascular Medicine at Mayo and a board director at InfoBionic.Ai. “By

Technology 105

Technology Heart Rhythm Innovation Heart Failure 105

The British Journal of Cardiology

DECEMBER 3, 2024

These innovative agents, initially developed for glycaemic control in type 2 diabetes, have unexpectedly demonstrated significant cardiovascular benefits, revolutionising cardiologists’ approach to the prevention and treatment of heart failure and cardiovascular events.

Innovation 40

Innovation Heart Failure Diabetes Article 40

HeartRhythm

SEPTEMBER 25, 2023

In heart failure with reduced ejection fraction and heart failure with preserved ejection fraction, profound cellular and molecular changes have recently been documented in the failing myocardium.These changes include altered calcium handling and metabolic efficiency of the cardiac myocyte, reactivation of the fetal gene program, changes in the electrophysiological (..)

Preserved Ejection Fraction 40

Preserved Ejection Fraction Electrophysiology Heart Failure Document 40

DAIC

JULY 9, 2024

“While cardiologists are not the only determinants of cardiovascular outcomes, the lack of access to cardiologists in areas with greater prevalence of heart disease and mortality is incredibly concerning,” said Haider J. Upon analyzing all 3,143 U.S. Krumholz, MD, SM, FACC.

Risk Factors 103

Risk Factors Cardiovascular Disease Webinar Public Health 103